BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc
georgie18
Member Level
Re: None
Tuesday, January 07, 2025 7:47:47 AM
Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
georgie18
Member Level
Re: None
Tuesday, January 07, 2025 7:47:47 AM
Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
Recent BDSX News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/21/2026 08:39:10 PM
- Biodesix to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/21/2026 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:18:43 PM
- Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy • GlobeNewswire Inc. • 05/11/2026 01:17:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/08/2026 09:00:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/04/2026 08:05:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:03:15 PM
- Biodesix Announces First Quarter 2026 Results and Highlights • GlobeNewswire Inc. • 05/04/2026 08:01:00 PM
- Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026 • GlobeNewswire Inc. • 04/20/2026 10:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/09/2026 08:21:26 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/09/2026 08:14:05 PM
- Biodesix Recognized as a Top Workplace for Third Consecutive Year • GlobeNewswire Inc. • 04/09/2026 05:19:00 PM
- Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development • GlobeNewswire Inc. • 04/06/2026 03:43:00 PM
- Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis • GlobeNewswire Inc. • 03/20/2026 12:06:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:02:25 PM
- Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights • GlobeNewswire Inc. • 02/26/2026 09:01:00 PM
- Biodesix to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/24/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 01:22:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 01:22:24 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 01:22:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 01:22:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 01:22:20 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/24/2026 01:22:19 AM
- Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 • GlobeNewswire Inc. • 02/12/2026 11:00:00 AM
